Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Iscience
|
October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer
Emil Lou, Christine Luo, Katherine Ladner, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
BMC Cancer
|
March 13, 2025
Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer
Mingli Yang, Michael V Nebozhyn, Michael J Schell, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Annals of Surgery
|
October 28, 2025
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study
Julia Button, Elishama Kanu, Ethan Agritelley, et al.
Frontiers in Oncology
|
May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer types
Laura Schubert, Andrew Elliott, Anh T Le, et al.
Human Pathology
|
July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas
Anastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A Philip, Ibrahim Azar, Joanne Xiu, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Iscience
|
October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer
Emil Lou, Christine Luo, Katherine Ladner, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
BMC Cancer
|
March 13, 2025
Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer
Mingli Yang, Michael V Nebozhyn, Michael J Schell, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Annals of Surgery
|
October 28, 2025
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study
Julia Button, Elishama Kanu, Ethan Agritelley, et al.
Frontiers in Oncology
|
May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer types
Laura Schubert, Andrew Elliott, Anh T Le, et al.
Human Pathology
|
July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas
Anastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A Philip, Ibrahim Azar, Joanne Xiu, et al.
Page
of 19